Go Pro
NASDAQ:NXL

Nexalin Technology Q3 2025 Earnings Report

Nexalin Technology logo
$5.73 -1.82 (-24.11%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$5.48 -0.25 (-4.31%)
As of 10/2/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology EPS Results

Actual EPS
-$3.90
Consensus EPS
-$3.60
Beat/Miss
Missed by -$0.30
One Year Ago EPS
N/A

Nexalin Technology Revenue Results

Actual Revenue
$0.02 million
Expected Revenue
$0.04 million
Beat/Miss
Missed by -$21.85 thousand
YoY Revenue Growth
N/A

Nexalin Technology Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Friday, November 14, 2025
Conference Call Time
7:00AM ET

Upcoming Earnings

Nexalin Technology's Q3 2026 earnings is estimated for Wednesday, December 2, 2026, based on past reporting schedules

Earnings Documents

Nexalin Technology Earnings Headlines

Zacks Research Upgrades Nexalin Technology (NASDAQ:NXL) to Hold
What is Maxim Group's Forecast for NXL Q3 Earnings?
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
These Stocks Roar into October with Fresh Catalysts
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL) is a medical technology company focused on developing noninvasive neurostimulation devices designed to support brain health. Its technology uses cranial electrotherapy stimulation to deliver low-level electrical signals through electrodes placed on the head, with the aim of influencing brain activity without surgery or implanted hardware.

The company’s product portfolio includes the Nexalin Gen-2 and Gen-3 devices, which are designed for use in clinical and other supervised settings. Nexalin has pursued applications for conditions and symptoms including insomnia, anxiety, depression and post-traumatic stress disorder, although the regulatory status and approved uses of its products may vary by jurisdiction.

Nexalin Technology has worked to commercialize its devices in the United States and international markets through regulatory initiatives, clinical research and distribution relationships. The company’s operations are centered on advancing its neurostimulation platform and expanding access to its products for healthcare providers and patients.

View Nexalin Technology Profile